130A.T
Veritas In Silico Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 434.00
+0.23%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-39.4%
Return on equity
-33.7%
Return on assets
-28.6%
Return on invested capital
—
Asset turnover
-JPY 299.0M
Cash from operations
JPY 264
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026